INSMED INC's ticker is and the CUSIP is 457669AB5. A total of 58 filers reported holding INSMED INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,623,484 | +96.7% | 14,031,000 | 0.0% | 0.09% | +72.2% |
| Q1 2024 | $15,062,279 | -56.3% | 14,031,000 | -53.3% | 0.05% | -48.1% |
| Q4 2023 | $34,445,555 | +27.8% | 30,031,000 | +11.1% | 0.10% | -14.0% |
| Q3 2023 | $26,949,907 | -54.4% | 27,031,000 | -61.4% | 0.12% | -58.6% |
| Q2 2023 | $59,046,469 | +49.0% | 69,981,000 | +37.3% | 0.29% | +46.0% |
| Q1 2023 | $39,635,250 | -34.1% | 50,981,000 | -29.7% | 0.20% | -54.3% |
| Q4 2022 | $60,159,230 | -1.1% | 72,481,000 | +9.2% | 0.44% | +19.3% |
| Q3 2022 | $60,835,000 | +17.5% | 66,377,000 | +7.3% | 0.37% | +45.1% |
| Q2 2022 | $51,791,000 | +57.8% | 61,877,000 | +82.7% | 0.25% | +181.1% |
| Q1 2022 | $32,827,000 | +0.9% | 33,877,000 | +13.4% | 0.09% | +66.7% |
| Q4 2021 | $32,521,000 | +24.0% | 29,877,000 | +25.1% | 0.05% | +3.8% |
| Q3 2021 | $26,220,000 | +163.8% | 23,877,000 | +165.3% | 0.05% | +136.4% |
| Q2 2021 | $9,939,000 | – | 9,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boussard & Gavaudan Investment Management LLP | 13,309 | $27,631,294 | 4.40% |
| LINDEN ADVISORS LP | 117,570,000 | $248,670,498 | 2.08% |
| WHITEBOX ADVISORS LLC | 34,050,000 | $71,804,235 | 2.05% |
| CSS LLC/IL | 16,586,000 | $35,104,518 | 1.80% |
| 683 Capital Management, LLC | 10,428,000 | $22,084,731 | 1.67% |
| Graham Capital Management, L.P. | 33,206,000 | $70,236,494 | 1.53% |
| SSI INVESTMENT MANAGEMENT LLC | 8,495,000 | $17,914,155 | 1.38% |
| Baker Brothers Advisors | 42,850,000 | $90,413,500 | 1.16% |
| DeepCurrents Investment Group LLC | 10,000,000 | $21,153,059 | 0.83% |
| Warberg Asset Management LLC | 2,500,000 | $5,289,763 | 0.80% |